You searched for "refraction"

2902 results found

Cytotoxic effect of voriconazole on human corneal epithelial cells

Voriconazole is a second-generation synthetic derivative of fluconazole with broadened antifungal spectrum. It is becoming the drug of choice for fungal keratitis. Voriconazole eye drops are not available commercially, thus have to be prepared by diluting the intravenous formulation containing...

Evaluation of ectopia lentis et pupillae (ELP)

The ADAMTSL4 gene encodes proteins for cellular adhesion, angiogenesis, nervous system development and anterior / posterior segment structures. This case report describes a four-year-old female with diagnosis at referral of ELP. A three-generation pedigree was obtained and was negative for...

Survey of paediatric ophthalmology practice in the US

The purpose of this study was to develop a survey to assess possible solutions for an economic turnaround in paediatric ophthalmology. A 12-item survey was circulated with questions related to practice location, setting and years in practice. Responses were received...

Global Experts Unite: Visionary Horizons Sets the Stage for the Future of Ophthalmology

Heidelberg Engineering, as part of EssilorLuxottica, marked a milestone in global eyecare innovation with the inaugural Visionary Horizons symposium — the first event of its kind showcasing Heidelberg’s pioneering innovation and expertise as a driving force within EssilorLuxottica’s technological and...

Comparison of structural and functional features in primary angle closure and open-angle glaucoma

In this large cross-sectional study, differences in structural and functional damage were assessed among patients with primary open-angle glaucoma (POAG) and primary angle closure glaucoma (PACG) with optical coherence tomography and reliable visual field testing. Two-hundred and eighty-three patients with...

Retinal Pharmacotherapeutics (Developments in Ophthalmology)

Retinal Pharmacotherapeutics is volume 55 in the ‘Developments in Ophthalmology’ series released by Karger. As the name of the series suggests it aims to explore current and future developments in retinal therapeutics. The book itself is split into six main...

In conversation with Andy Pyott

Discussing a detour into ophthalmology from zoology in 1988, experiences in Asia, sub-Saharan Africa and Europe and the National Treatment Centre – Highland, Baljean Dhillon interviews his newest guest on the Eye Views podcast, Andy Pyott. Take us back to...

Post-stroke visual impairment: how big is the problem, how do we identify it, what we can do about it, and why does it matter?

In the UK, 100,000 new strokes occur each year, with 1.3 million stroke survivors [1]. This article will focus on post-stroke visual impairment, discussing topics of how common it is, how it can be detected, possible management options and how...

Broadening of treatment options for potentially blinding retinal conditions

Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...

Quantum imaging research could improve retinal scans

New EU-funded feasibility project is testing a quantum approach that could reveal finer detail in the eye than ever before. A European research consortium is exploring a new quantum imaging technique that could one day help clinicians see the earliest...

Keratoconus: When, Why and Why Not. A Step by Step Systematic Approach

This is a single author publication addressing the subject of ectatic corneal disorders and keratoconus (when, why, and why not) with a step by step systematic approach to management using modern sophisticated diagnostic and screening tools. It is comprised of...

Researchers pursue personalised pathways for glaucoma care

Researchers, funded by Glaucoma UK in partnership with The Royal College of Ophthalmologists, are investigating the potential for personalised glaucoma care by mapping clinical trial data and real-word outcomes to individuals.